MK-3475-C66
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Novartis
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Bristol-Myers Squibb
Pfizer
Seagen Inc.
Fate Therapeutics
Tianjin Medical University Cancer Institute and Hospital
Alterome Therapeutics, Inc.
Verastem, Inc.
Novartis
Revolution Medicines, Inc.
Hoffmann-La Roche
University of Chicago
Revolution Medicines, Inc.
Erasca, Inc.
Erasca, Inc.
Eastern Cooperative Oncology Group
Incyte Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
AstraZeneca
Incyte Corporation
Multitude Therapeutics Inc.
Eli Lilly and Company
Pfizer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
Tizona Therapeutics, Inc
Genentech, Inc.
Memorial Sloan Kettering Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Wisconsin, Madison
University of Campania Luigi Vanvitelli
Revolution Medicines, Inc.
Gruppo Oncologico Italia Meridionale